Navigation Links
IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at,2007 ASCO Annual Meeting

New York .

Forward-Looking Statements

This press release includes and the presentation described in this press release will include forward-looking statements that reflect management's current views of future events including statements regarding the phase II UVIDEM study and the potential for UVIDEM as a treatment for melanoma and the phase II EP-2101 study and the potential for EP-2101 as a treatment for NSCLC, and review of the submissions for marketing approval of JUNOVAN by the FDA and the EMEA. Actual results may differ materially from the forward-looking statements due to a number of important factors, including, but not limited to, the timing of the FDA's and EMEA's review of the submissions for marketing approval, the ability of the Company to respond to questions raised by the FDA and EMEA in a satisfactory manner, the time needed to respond to any issues raised by the FDA and EMEA with regard to regulatory submissions for JUNOVAN, although the FDA is not bound by the decision of any advisory panel, the possible negative impact that the opinion of the FDA's Oncologic Drug Advisory Committee that the results of the Company's Phase III trial do not provide substantial evidence of effectiveness of JUNOVAN in the treatment of patients with non-metastatic, resectable osteosarcoma receiving combination chemotherapy would have upon the determination by the FDA whether to approve the marketing application for JUNOVAN, which would have a material and adverse affect on IDM's business, the possibility that regulatory authorities may not consider preclinical and early clinical development work conducted by Ciba-Geigy and efficacy data from the Phase III trial conducted by Children's Oncology Group as adequate for their assessment of JUNOVAN, which may cause delays in review, may result in the regulatory authorities requiring the Company to conduct additional clinical trials, or may result in a determination by the regulatory authorities that the data do
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Sygnis Pharma AG announces date for presentation of clinical results
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
Post Your Comments:
(Date:5/18/2013)... 18, 2013 Although colonoscopy exams prevent many ... most sensitive method for detecting colorectal cancers 2 , ... cases 3 . EndoChoice ® Inc. today unveiled ... improves the accuracy of this procedure and greatly reduces ... be discussing these clinical trial results and featuring the ...
(Date:5/18/2013)... 18, 2013 The Open Paradigm Project, ... Occupy Psychiatry , and leading organizations in ... a social media campaign showcasing video testimonials by ... which focuses on pathology and illness rather than ... American Psychiatric Association,s (APA) rollout of its latest ...
(Date:5/18/2013)... May 18, 2013 Faruqi & Faruqi, ... investigating potential securities fraud at AVEO Pharmaceuticals, Inc. ... (Logo: http://photos.prnewswire.com/prnh/20120119/MM38856LOGO ) The ... executives violated federal securities laws by issuing materially ... III drug trials for Tivopath (tivozanib) (titled "TIVO-1").  ...
Breaking Medicine Technology:New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy 2New Study Shows Full Spectrum Endoscopy Procedure Reduces The 'Miss Rate' of Adenomas During Colonoscopy 3New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 2New Social Media Campaign Features Stories Of Individuals Who Rejected Psychiatric Diagnoses 3Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm 2
... 16, 2012  SCOLR Pharma, Inc. (OTCQB: SCLR) announced today ... on the Company,s patented oral drug delivery platform, ... products are now being sold under various private label ... chains.  Each product has been designed ...
... Though backed by a large and diverse coalition ... Bill, was denied a vote in the Washington State ... have required drug manufacturers selling medicines in Washington state ... program for left-over or expired medicines from residents – ...
Cached Medicine Technology:SCOLR Pharma, Inc. Launches Cutting Edge Nutritional Products at Major Retailers in 2012 2Bill Establishing Statewide Medicine Take-Back Fails to Reach Senate Vote 2Bill Establishing Statewide Medicine Take-Back Fails to Reach Senate Vote 3Bill Establishing Statewide Medicine Take-Back Fails to Reach Senate Vote 4
(Date:5/18/2013)... May 18, 2013 The Ayurvedic practitioner ... education institution in the West. Program is available in ... Ayurveda is a healing modality practiced for over 5,000 ... is considered that health begins when an individual lives ... of their individual needs. Ayurveda aims to heal an ...
(Date:5/18/2013)... Losing weight remains to be the biggest ... of new weight loss products available in the market today, ... about this newest weight loss supplement prove that dieting and ... Garcinia Cambogia is a sub-tropical fruit that is shaped like ... can suppress a person’s appetite, while it effectively burns fat ...
(Date:5/18/2013)... The topics that will be covered in the 1-day ... meetings, scrum artifacts, and scrum simulation (optional). One can earn ... These trainings are suitable for business analysts, project managers, developers, ... will be a part of the Scrum team, people outside ... and Scrum, but are unsure of what it is. ...
(Date:5/18/2013)... San Diego, CA (PRWEB) May 18, 2013 ... In its latest update to consumers about ... consolidated in federal court Resource4thePeople reports that ... litigation, according to court documents. , The ... in U.S. District Court in the Southern ...
(Date:5/18/2013)... (PRWEB) May 18, 2013 Three new ... two health and wellness centers and one therapeutic dispensary. ... three locations, the weekend of May 25th – May ... celebrating Memorial Day. All events will take ... May 25th , Elements Therapeutic Dispensary , 10580 S. ...
Breaking Medicine News(10 mins):Health News:Ayurveda Training in Mexico Offered by Escuela de Ayurveda de California, a Leading Institution in the West 2Health News:Lose Weight Without Dieting or Exercising with Garcinia Cambogia Select Now Available At HealthCareSupplementz.com 2Health News:Affordable Scrum Trainings In Irvine by Conscires Agile Practices 2Health News:Affordable Scrum Trainings In Irvine by Conscires Agile Practices 3Health News:2013 Alleged Transvaginal Mesh Complications Lawsuits Update: Resource4thePeople Reports Defendants Ordered to Provide Testimony, Documents 2Health News:2013 Alleged Transvaginal Mesh Complications Lawsuits Update: Resource4thePeople Reports Defendants Ordered to Provide Testimony, Documents 3Health News:2013 Alleged Transvaginal Mesh Complications Lawsuits Update: Resource4thePeople Reports Defendants Ordered to Provide Testimony, Documents 4Health News:Elements Honors Medical Marijuana Patients at Elements Health and Wellness Centers and Elements Therapeutic Dispensary 2Health News:Elements Honors Medical Marijuana Patients at Elements Health and Wellness Centers and Elements Therapeutic Dispensary 3Health News:Elements Honors Medical Marijuana Patients at Elements Health and Wellness Centers and Elements Therapeutic Dispensary 4
... have found that they have found new methods, which ... that a gene linked to inherited Parkinson's works by ... are the power centers of the cells. They are ... needs to move, divide and produce proteins. ...
... Researchers have now identified a new strategy to effectively ... that it is spread through a complex interaction// of ... an interaction is believed to pave way for viral ... State University and the University of Florida have identified ...
... revealed in Grampian. NHS there has stopped giving the information because ... are not being told about it. ,A spokesperson said, "We ... wrong but because of time management. It can take two or ... aggregate that over a day or week or month it adds ...
... likely to face death earlier than those of the same ... causes of the deaths of large numbers of patients in ... with Type 2 diabetes aged 35 to 54 were three ... same age, reported the online edition of BBC News. ...
... consent of patients prior to medical trials, a famous eye ... from the patients. ,Dr Deepak Chitkara, 46, from ... "untested" lenses into patients' eyes as part of a study. ... Eye clinic, but has since started his own practice. ...
... Germany have developed new tests that would determiner the ... de Mayo or just having another relaxing day in ... from fraudulent versions, which are a potential threat as ... findings could help provide a "shot" of quality assurance ...
Cached Medicine News:Health News:Researchers Have Found New Methods To Treat Parkinson’s Diseas 2Health News:West Nile Virus Can Be Tackled By New Strategy 2Health News:West Nile Virus Can Be Tackled By New Strategy 3Health News:Tequila-The Real Stuff or Not 2
... market:, ,QuietLife 3 is the ... oxygen concentrator for home health and ... attractive, lightweight (26 kg) cabinet, this ... the requirements of the sound-sensitive, energy-conscious ...
... AirSep's new QuietLife 5 Oxygen Concentrator is ... that delivers continuous flow oxygen for prescriptions ... ,As the quietest running concentrator at ... sound-sensitive patients or caregivers. Concentrators are also ...
... NewLife Elite is AirSep Corporations most economical ... to 5 lpm of therapeutic oxygen in ... of thousands of units in daily use ... concentrator is known for high performance, easy ...
OCD-3000 pnuematic conserving regulator....
Medicine Products: